Literature DB >> 8133802

Characterization of Vibrio cholerae O139 synonym Bengal isolated from patients with cholera-like disease in Bangladesh.

N Higa1, Y Honma, M J Albert, M Iwanaga.   

Abstract

Vibrio cholerae O139 (synonym Bengal), a novel serovar of V. cholerae, is the causative agent of large outbreaks of cholera-like illness currently sweeping India and Bangladesh. Eight randomly selected V. cholerae O139 isolates were studied for their biological properties, which were compared with those of V. cholerae O1 and other V. cholerae non-O1. The V. cholerae O139 isolates were characterized by the production of large amount of cholera toxin, hemagglutination, weak hemolytic properties, resistance to polymyxin B, lysogeny with, and production of, kappa type phage (4/8 isolates only), and resistance to both classical and El Tor-specific phages. Thus, V. cholerae O139 isolates had an overall similarity with V. cholerae O1 El Tor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8133802     DOI: 10.1111/j.1348-0421.1993.tb01731.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  10 in total

1.  PLASMID MEDIATED DRUG RESISTANCE IN VIBRIO CHOLERAE 0139 BENGAL.

Authors:  R N Misra; N K Debata; A Nagend; T S Hyder; V C Ohri
Journal:  Med J Armed Forces India       Date:  2017-06-26

2.  Characterization of the major control region of Vibrio cholerae bacteriophage K139: immunity, exclusion, and integration.

Authors:  J Nesper; J Blass; M Fountoulakis; J Reidl
Journal:  J Bacteriol       Date:  1999-05       Impact factor: 3.490

Review 3.  Vibrio cholerae O139 Bengal.

Authors:  M J Albert
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

4.  Role of Vibrio cholerae O139 surface polysaccharides in intestinal colonization.

Authors:  Jutta Nesper; Stefan Schild; Crystal M Lauriano; Anita Kraiss; Karl E Klose; Joachim Reidl
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

5.  Comparative and genetic analyses of the putative Vibrio cholerae lipopolysaccharide core oligosaccharide biosynthesis (wav) gene cluster.

Authors:  Jutta Nesper; Anita Kraiss; Stefan Schild; Julia Blass; Karl E Klose; Jochen Bockemühl; Joachim Reidl
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

6.  Immune mechanisms and protective antigens of Vibrio cholerae serogroup O139 as a basis for vaccine development.

Authors:  G Jonson; J Osek; A M Svennerholm; J Holmgren
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

7.  Characterization of vibrio cholerae O1 antigen as the bacteriophage K139 receptor and identification of IS1004 insertions aborting O1 antigen biosynthesis.

Authors:  J Nesper; D Kapfhammer; K E Klose; H Merkert; J Reidl
Journal:  J Bacteriol       Date:  2000-09       Impact factor: 3.490

8.  The Vibrio cholerae O139 serogroup antigen includes an O-antigen capsule and lipopolysaccharide virulence determinants.

Authors:  M K Waldor; R Colwell; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

9.  Elucidation of a novel Vibrio cholerae lipid A secondary hydroxy-acyltransferase and its role in innate immune recognition.

Authors:  Jessica V Hankins; James A Madsen; David K Giles; Brandon M Childers; Karl E Klose; Jennifer S Brodbelt; M Stephen Trent
Journal:  Mol Microbiol       Date:  2011-07-18       Impact factor: 3.501

Review 10.  Emerging bacterial pathogens: the past and beyond.

Authors:  M Vouga; G Greub
Journal:  Clin Microbiol Infect       Date:  2015-10-19       Impact factor: 8.067

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.